Skip to Main Content

Paper Details

Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia.
Nat Commun
104
2019
AML, Brd4, Cas9, Irf8, Kdm1a, Lsd1, Pu.1, acute myeloid leukaemia, cancers, enhancer, enhancers, mouse, patient, resistant cell state, single, survival genes
Author NameAffiliation
Luciano G MartelottoUniversity of Melbourne
Helai P MohammadCollegeville
Anthony T PapenfussPeter MacCallum Cancer Centre
Anthony T PapenfussThe University of Melbourne
Anthony T PapenfussThe Walter and Eliza Hall Institute of Medical Research
Sean M GrimmondUniversity of Melbourne
Sean M GrimmondUniversity of Melbourne
Rab K PrinjhaCollegeville
  • 1 - 8

Datasets

Release 1.2